AB
STLN

Amalgamated Bank’s Starling Oncology STLN Stock Holding History

Amalgamated Bank’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,144
Closed -$8K – 2720
2025
Q4 		$8K Buy
2,144
+128
+6% +$475 ﹤0.01% 2544
2025
Q3 		$7K Hold
2,016
– – ﹤0.01% 2636
2025
Q2 		$4K Buy
+2,016
New +$5.04K ﹤0.01% 2885
2023
Q2 		– Sell
-5,104
Closed -$3K – 3120
2023
Q1 		$3K Buy
5,104
+241
+5% +$307 ﹤0.01% 2927
2022
Q4 		$8K Hold
4,863
– – ﹤0.01% 2902
2022
Q3 		$23K Buy
4,863
+1,894
+64% +$11.1K ﹤0.01% 2780
2022
Q2 		$15K Buy
+2,969
New +$21.6K ﹤0.01% 2921

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $413M AUM 109.83% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amalgamated Bank's STLN Position: Q1 2026 in Review

Amalgamated Bank sold out of Starling Oncology (STLN) in Q1 2026, closing a stake of 2,144 shares — an estimated $8K sold.

Amalgamated Bank first reported a position in STLN in Q2 2022 and held it in 7 quarters. The position peaked at $23K in Q3 2022. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Amalgamated Bank reported no remaining Starling Oncology position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,144 Starling Oncology shares in Q1 2026, an estimated $8K.
  • Amalgamated Bank first reported a position in Starling Oncology in Q2 2022 and held it in 7 quarters.
  • Amalgamated Bank's Starling Oncology position peaked at $23K in Q3 2022.
  • 115 funds tracked by Wall St. Rank held Starling Oncology as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.